New heart drug trial aims to reverse dangerous heart thickening
Disease control
Not yet recruiting
This study is testing whether adding the drug finerenone to standard heart failure care can improve the heart's structure and function in people at risk for heart and kidney problems. About 156 participants with a thickened heart muscle will take either finerenone or a placebo pi…
Phase: PHASE3 • Sponsor: Subodh Verma • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC